Chloroplast Biotechnology

Chloroplast is the structure within the cells of plants and green algae that is the site of photosynthesis, the process by which light energy is converted to chemical energy, resulting in the production of oxygen and energy-rich organic compounds. Chloroplast genetic engineering research has a lot of potential in biomedical applications. The primary treatment for diabetes is insulin, which is currently produced in fermentation systems
Chloroplast is used to develop protein drugs for a number of disease. For example, hypertension is caused by deficiency of two proteins, angiotensin-converting enzyme and angiotensin. The new treatment introduces these proteins through lettuce capsules and prevent the onset of hypertension of reverse hypertension. Similarly, Alzheimer’s is caused by plaques developing in the brain. Chloroplast biotechnology was used to introduce enzyme which can clear these plaques and restore normal function.
  • Track 1-1 Technical Advances in Chloroplast Biotechnology
  • Track 2-2 Advances in chloroplast genome sequencing technology
  • Track 3-3 Chloroplasts as trouble-rescue organelles
  • Track 4-4 Advances in plastid functional genomics
  • Track 5-5 RNA editing in chloroplasts
  • Track 6-6 Plastid Genomes and Cell Biology
  • Track 7-7 Fine-Tuning Post-Transcriptional Regulation
  • Track 8-8 Recombinant Protein Expression

Related Conference of Genetics & Molecular Biology